Webinars and Events | March 16, 2023

The End of COVID-19 Emergencies

On January 30, 2023, the Biden Administration announced it would end both the public health emergency (PHE) and national emergency (NE) related to COVID-19 effective May 11, 2023. As healthcare costs related to COVID-19 begin to transition, plan sponsors will need to make decisions whether to continue to allow coverage and flexibility under the PHE and NE rules, go back to pre-COVID-19 rules or compromise somewhere in the middle.

Doctor Applying A Band Aid After Injecting Her Patient During A Consultation In The Clinic

In this webinar...

Our experts discussed the considerations for plan sponsors and provided data and additional details to help determine the best path forward, including:

  • The emergency ending and what that transition means for health plans
  • COVID-19 costs and the transition impact to plan sponsors and participants
  • Communication requirements and best practices to keep participants informed

Webinar Replay

 

Speakers

Kathryn Bakich, Senior Vice President, Health Compliance Practice Leader
Jason Jossie, Senior Health Consultant
Angela Purdum, Vice President, Communications

Get the Slides

Don’t have time to watch a video right now? No worries. Here is a copy of the slides from this session.

Download Now

See more insights

Teacher In Classroom Points To Student Raising Hand

Webinar: How Do State Employee Health Benefits Compare?

See how your state employee health benefits compare to your peers. Our May 1 webinar features insights on health plans in all 50 states.
Asian Malay Female Smiling Customer Scouting Product At Shelf Of Pharmacy

Health Accounts Can't Be Used for General Health Expenses

Reimbursable medical expenses: Full details on what the IRS says can — and can’t — be paid for with HRAs, HSAs and FSAs, plus IRS health expense FAQs.
A Man In His 50S Is Holding Pill Bottles While Searching For Information Online

Guidance Clarifies RDS and Creditable Coverage Calculation

Sponsors of retiree health plans: Learn key aspects on how the CMS final guidance on changes to Medicare Part D prescription drug program impacts you.

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.